| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |